258 related articles for article (PubMed ID: 17895938)
1. [Prescribing of stimulants for ADHD in Nordland County].
Asheim H; Nilsen KB; Johansen K; Furu K
Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2360-2. PubMed ID: 17895938
[TBL] [Abstract][Full Text] [Related]
2. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
3. [Prescription of central nervous system stimulants].
Asheim H; Nilsen KB; Stordahl H; Johansen K
Tidsskr Nor Laegeforen; 2001 Mar; 121(8):908-10. PubMed ID: 11332376
[TBL] [Abstract][Full Text] [Related]
4. Prescriptions for ADHD medication, 2004-08.
Lillemoen PK; Kjosavik SR; Hunskår S; Ruths S
Tidsskr Nor Laegeforen; 2012 Sep; 132(16):1856-60. PubMed ID: 22986969
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.
Hodgkins P; Sasané R; Meijer WM
Clin Ther; 2011 Feb; 33(2):188-203. PubMed ID: 21497704
[TBL] [Abstract][Full Text] [Related]
6. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
7. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
8. Prescribed stimulant use by Western Australians with Attention Deficit Hyperactivity Disorder (ADHD): does amount dispensed exceed the expected authorised use?
Calver J; Sanfilippo F; Preen D; Bulsara M
Aust N Z J Public Health; 2007 Dec; 31(6):533-9. PubMed ID: 18081573
[TBL] [Abstract][Full Text] [Related]
9. [Use of methylphenidate among children in Iceland 1989-2006].
Zoëga H; Baldursson G; Halldórsson M
Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
[TBL] [Abstract][Full Text] [Related]
10. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
Sasané R; Hodgkins P; Meijer W
Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
[TBL] [Abstract][Full Text] [Related]
11. [Increasing trend in prescription of methylphenidate in general practices in the north-east of The Netherlands, 1998-2003].
Donker GA; Groenhof F; van der Veen WJ
Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1742-7. PubMed ID: 16114292
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study.
Norum J; Olsen AI; Nohr FI; Heyd A; Totth A
Glob J Health Sci; 2014 Apr; 6(4):155-62. PubMed ID: 24999151
[TBL] [Abstract][Full Text] [Related]
13. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
14. [Hyperactivity and prescription of Ritalin in the canton of Vaud (Switzerland), 2002].
Huissoud T; Jeannin A; Dubois-Arber F
Rev Epidemiol Sante Publique; 2007 Oct; 55(5):357-63. PubMed ID: 17889474
[TBL] [Abstract][Full Text] [Related]
15. [Is Ritalin prescribed insufficiently to hyperactive children in Nordland?].
Neraal T
Tidsskr Nor Laegeforen; 2001 May; 121(14):1735-6. PubMed ID: 11446022
[No Abstract] [Full Text] [Related]
16. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel--a controversial issue.
Fogelman Y; Kahan E
Isr Med Assoc J; 2001 Dec; 3(12):925-7. PubMed ID: 11794916
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy with atomoxetine for US children and adolescents.
Bhatara VS; Aparasu RR
Ann Clin Psychiatry; 2007; 19(3):175-80. PubMed ID: 17729019
[TBL] [Abstract][Full Text] [Related]
18. Trends in medication treatment for ADHD.
Castle L; Aubert RE; Verbrugge RR; Khalid M; Epstein RS
J Atten Disord; 2007 May; 10(4):335-42. PubMed ID: 17449832
[TBL] [Abstract][Full Text] [Related]
19. Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006.
van den Ban E; Souverein P; Swaab H; van Engeland H; Heerdink R; Egberts T
J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):55-61. PubMed ID: 20166797
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate patterns among Medicaid youths.
Zito JM; Safer DJ; dosReis S; Magder LS; Riddle MA
Psychopharmacol Bull; 1997; 33(1):143-7. PubMed ID: 9133766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
